PEPTIDE-GBM1

1 study on PEPTIDE-GBM1 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on PEPTIDE-GBM1. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

PEPTIDE-GBM1 studies and clinical research

2026-04-25 PubMed · preclinical animal · n preclinical

AI Designs Novel Peptides to Combat Aggressive Brain Cancer

This study represents a significant breakthrough by demonstrating the power of generative AI in discovering and validating novel therapeutic peptides for challenging diseases like glioblastoma. The potent anti-tumor e…

Research tools

Free, no account — handy when you're working with PEPTIDE-GBM1.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$12 monthly or $33 lifetime

Create free account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

PEPTIDE-GBM1 studies and clinical research

AI Designs Novel Peptides to Combat Aggressive Brain Cancer

Research tools